<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ASH &#62; Action on Smoking &#38; Health &#187; Philip Morris</title>
	<atom:link href="http://ash.org/tag/philip-morris/feed/" rel="self" type="application/rss+xml" />
	<link>http://ash.org</link>
	<description></description>
	<lastBuildDate>Fri, 07 Jun 2013 20:22:06 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4</generator>
		<item>
		<title>Do We Get Sick Like Rats? A New Philip Morris Prize Asks the Crowd</title>
		<link>http://ash.org/do-we-get-sick-like-rats-a-new-philip-morris-prize-asks-the-crowd/</link>
		<comments>http://ash.org/do-we-get-sick-like-rats-a-new-philip-morris-prize-asks-the-crowd/#comments</comments>
		<pubDate>Wed, 01 May 2013 14:18:51 +0000</pubDate>
		<dc:creator>ash</dc:creator>
				<category><![CDATA[Featured News & Events]]></category>
		<category><![CDATA[Related News]]></category>
		<category><![CDATA[Philip Morris]]></category>
		<category><![CDATA[PMI]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Tobacco Industry]]></category>

		<guid isPermaLink="false">http://ash.org/?p=2330</guid>
		<description><![CDATA[It might be surprising to hear a tobacco giant described as a tech innovator. But Philip Morris researchers are pioneering new territory with a crowdsourced approach to checking the accuracy of life sciences data. In partnership with computational biologists at IBM’s Watson Research Center, Philip Morris’s so-called sbv IMPROVER project creates open challenges to encourage scientists to<a class="moretag" href="http://ash.org/do-we-get-sick-like-rats-a-new-philip-morris-prize-asks-the-crowd/">... Read the full article ></a>]]></description>
			<content:encoded><![CDATA[<p>It might be surprising to hear a tobacco giant described as a tech innovator. But Philip Morris researchers are pioneering new territory with a crowdsourced approach to checking the accuracy of life sciences data.</p>
<p>In partnership with computational biologists at IBM’s Watson Research Center, Philip Morris’s so-called <a href="https://www.sbvimprover.com/">sbv IMPROVER</a> project creates open challenges to encourage scientists to augment traditional peer reviews of research data. On Monday, Philip Morris launched its Species Translation Challenge, which will award three $20,000 prizes to teams whose results best define how well rodent tests can predict human outcomes.</p>
<p>Similar competitions have emerged in the academic world, but sbv IMPROVER (short for “systems biology verification of industrial methodology for process verification in research” in case you were wondering) is the first that taps the crowd to verify industrial research. An initial challenge last year awarded $50,000 to two Wayne State University researchers who proved best at confirming genetic features that could be considered “diagnostic signatures” for particular diseases.</p>
<p>Why is a cigarette manufacturer sponsoring such competitions? “Our number one objective is to do something about our dangerous products,” says Philip Morris scientific communications director, Hugh Browne. (The company is known for its periodic candor about such matters, even as it continues to dominate the industry.) From heart disease to cancer to emphysema, the potential consequences of smoking are well known. But <a href="http://www.utsouthwestern.edu/life-at/med-talks/why-do-smokers-never-get-lung-cancer.html">not every smoker suffers</a> all or any of those health effects, suggesting that a combination of environmental and genetic factors lead to disease.</p>
<p>To understand precisely how smoking and chewing tobacco leads to complex interactions in a user’s biological systems, “Philip Morris is increasing its investments into systems biology,” Browne says. The company is looking at networks of genes, proteins, and biochemical reactions to identify the exact biological mechanisms perturbed by smoking.</p>
<p>But such biological data is notoriously complex to analyze. The profession as yet lacks any standard methodology for verifying results, and traditional peer-review methods have “struggled with the volume and complexity of the data,” according to Philip Morris.</p>
<p><a href="http://techonomy.com/2013/04/do-we-get-sick-like-rats-a-new-philip-morris-prize-asks-the-crowd/" target="_blank">Read the full article at its original location&gt;</a></p>
]]></content:encoded>
			<wfw:commentRss>http://ash.org/do-we-get-sick-like-rats-a-new-philip-morris-prize-asks-the-crowd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Philip Morris International Expands its Portfolio</title>
		<link>http://ash.org/philip-morris-international-expands-its-portfolio/</link>
		<comments>http://ash.org/philip-morris-international-expands-its-portfolio/#comments</comments>
		<pubDate>Mon, 20 Aug 2012 13:42:08 +0000</pubDate>
		<dc:creator>ash</dc:creator>
				<category><![CDATA[Related News]]></category>
		<category><![CDATA[Eye on Tobacco]]></category>
		<category><![CDATA[Eye on Tobacco Industry]]></category>
		<category><![CDATA[Philip Morris]]></category>

		<guid isPermaLink="false">http://ash.org/?p=1508</guid>
		<description><![CDATA[Dips toe into alternative tobacco products worldwide NEW YORK &#8211; Philip Morris International, the largest tobacco company in the world recently announced yet another stream of revenue growth. With more regulation threats being imposed on tobacco companies and smokers, Philip Morris is looking to explore alternatives, according to a contributed column on Seeking Alpha. Governments<a class="moretag" href="http://ash.org/philip-morris-international-expands-its-portfolio/">... Read the full article ></a>]]></description>
			<content:encoded><![CDATA[<h5>Dips toe into alternative tobacco products worldwide</h5>
<div>
<p><strong>NEW YORK &#8211;</strong> Philip Morris International, the largest tobacco company in the world recently announced yet another stream of revenue growth. With more regulation threats being imposed on tobacco companies and smokers, Philip Morris is looking to explore alternatives, according to a contributed column on Seeking Alpha.</p>
<p>Governments globally have been attempting to regulate how and if cigarette companies can advertise. In addition, governments have hiked tax rates on cigarettes in an attempt to break people&#8217;s addictions by robbing their wallets. Philip Morris has responded by beginning to seek revenue through electronic cigarettes, chewing tobacco and snuff.</p>
<p>Though Philip Morris&#8217; smokeless effort is minimal right now compared to the tobacco industry, the company does have revenue coming from their joint venture with Swedish Match AB in 2009. The smokeless products from this joint venture are currently being marketed and sold in Russia and Canada. Revenues are expected to grow significantly too, as this is only the beginning of their marketing campaign, the column states.</p>
<p>Philip Morris is also looking to follow in the footsteps of competitor British American Tobacco and begin marketing electronic cigarettes. Electronic cigarettes offer a somewhat healthier alternative to traditional cigarettes because when you smoke them, you inhale water vapor mixed with nicotine rather than harmful smoke. This is easier on your lungs, although the nicotine still has its normal effects. With consumers becoming more aware of the consequences of smoking, some have looked to electronic cigarettes as an alternative to help preserve their lung function.</p>
<p>Long-term Philip Morris believes that electronic cigarettes will expand its revenue opportunities worldwide, the writer states. Philip Morris has the highest EPS growth rate among the tobacco sector for the next fiscal year; it&#8217;s estimated to be 11.2%, ahead of Lorillard, Altria Group and Reynolds American. Its revenue growth for next year is also expected to triumph in its sector by growing by a projected 5.51%. Philip Morris yields 3.3% at its current price.</p>
<p>CSP Daily News</p>
<p><a href="http://www.cspnet.com/news/tobacco/articles/philip-morris-international-expands-its-portfolio" target="_blank">See this article at its original location &gt;</a></p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://ash.org/philip-morris-international-expands-its-portfolio/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>